Anti-SLAMF7 / CS1 (PDL241)
Anti-SLAMF7 / CS1 (PDL241) is a novel humanized monoclonal antibody, targeting CD319. It is a promising therapeutic target for rheumatoid arthritis. MW :144.92 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3062 |
| Sku # | A3062-1mg*25 |
| Pricing | 1mg*25, $5070.00 |